BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Prognosis
13 results:

  • 1. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
    Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
    Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer.
    Rah B; Banday MA; Bhat GR; Shah OJ; Jeelani H; Kawoosa F; Yousuf T; Afroze D
    World J Gastroenterol; 2021 Sep; 27(36):6093-6109. PubMed ID: 34629822
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I.
    Ishihara S; Yamada Y; Iwasaki T; Yoshimoto M; Toda Y; Kohashi K; Yamamoto H; Matsumoto Y; Nakashima Y; Oda Y
    Oncol Rep; 2021 Jan; 45(1):379-389. PubMed ID: 33155664
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
    Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
    Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options.
    Tlemsani C; Leroy K; Gimenez-Roqueplo AP; Mansuet-Lupo A; Pasmant E; Larousserie F; Boudou-Rouquette P; Vidaud M; Cadranel J; Blons H; Goldwasser F; Laurent-Puig P
    J Med Genet; 2020 Feb; 57(2):104-108. PubMed ID: 30352869
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radiogenic angiosarcoma of the breast: case report and systematic review of the literature.
    Dogan A; Kern P; Schultheis B; Häusler G; Rezniczek GA; Tempfer CB
    BMC Cancer; 2018 Apr; 18(1):463. PubMed ID: 29690864
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.
    Zhang N; Liu H; Yue G; Zhang Y; You J; Wang H
    PLoS One; 2016; 11(4):e0153546. PubMed ID: 27077911
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families.
    Brieger A; Engels K; Schaefer D; Plotz G; Zeuzem S; Raedle J; Trojan J
    Fam Cancer; 2011 Sep; 10(3):591-5. PubMed ID: 21598002
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
    de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
    Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression.
    Alldinger I; Schaefer KL; Goedde D; Ottaviano L; Dirksen U; Ranft A; Juergens H; Gabbert HE; Knoefel WT; Poremba C
    J Cancer Res Clin Oncol; 2007 Oct; 133(10):749-59. PubMed ID: 17530287
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
    Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
    Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Expression of genes of potential importance in the response to chemotherapy in osteosarcoma patients].
    Nathrath M; Kremer M; Letzel H; Remberger K; Höfler H; Ulle T
    Klin Padiatr; 2002; 214(4):230-5. PubMed ID: 12165907
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
    Kleer CG; Giordano TJ; Braun T; Oberman HA
    Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.